Fabrication of pRNA nanoparticles to deliver therapeutic RNAs and bioactive compounds into tumor cells.
about
Crystal structure of 3WJ core revealing divalent ion-promoted thermostability and assembly of the Phi29 hexameric motor pRNADiscovery of a new motion mechanism of biomotors similar to the earth revolving around the sun without rotation.Functional assays for specific targeting and delivery of RNA nanoparticles to brain tumorCommon mechanisms of DNA translocation motors in bacteria and viruses using one-way revolution mechanism without rotationNanobiomotors of archaeal DNA repair machineries: current research status and application potentialEnhancing immunomodulation on innate immunity by shape transition among RNA triangle, square and pentagon nanovehicles.Regression of Gastric Cancer by Systemic Injection of RNA Nanoparticles Carrying both Ligand and siRNA.Bioresponsive antisense DNA gold nanobeacons as a hybrid in vivo theranostics platform for the inhibition of cancer cells and metastasis.RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases.Delivery of RNA nanoparticles into colorectal cancer metastases following systemic administration.Construction of RNA-Quantum Dot Chimera for Nanoscale Resistive Biomemory Application.A glucose carbonate apatite complex exhibits in vitro and in vivo anti-tumour effectsRibozyme-Spherical Nucleic AcidsRNA as a stable polymer to build controllable and defined nanostructures for material and biomedical applicationsNew approach to develop ultra-high inhibitory drug using the power function of the stoichiometry of the targeted nanomachine or biocomplex.Programmable folding of fusion RNA in vivo and in vitro driven by pRNA 3WJ motif of phi29 DNA packaging motor.The XXIIIrd Phage/Virus Assembly MeetingStable RNA nanoparticles as potential new generation drugs for cancer therapy.Discovery of a new method for potent drug development using power function of stoichiometry of homomeric biocomplexes or biological nanomotorsControllable self-assembly of RNA dendrimersAdvancement of the Emerging Field of RNA Nanotechnology.Finding of widespread viral and bacterial revolution dsDNA translocation motors distinct from rotation motors by channel chirality and sizeControllable Self-Assembly of RNA Tetrahedrons with Precise Shape and Size for Cancer Targeting.Fabrication of RNA 3D Nanoprisms for Loading and Protection of Small RNAs and Model Drugs.Physicochemically tunable polyfunctionalized RNA square architecture with fluorogenic and ribozymatic properties.Construction of RNA nanocages by re-engineering the packaging RNA of Phi29 bacteriophage.RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21.Size, Shape, and Sequence-Dependent Immunogenicity of RNA Nanoparticles.RNA Nanotherapeutics for the Amelioration of Astroglial Reactivity.Using Planar Phi29 pRNA Three-Way Junction to Control Size and Shape of RNA Nanoparticles for Biodistribution Profiling in Mice.Overcoming Tamoxifen Resistance of Human Breast Cancer by Targeted Gene Silencing Using Multifunctional pRNA Nanoparticles.Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy.RNA-based micelles: A novel platform for chemotherapeutic drug loading and delivery.The Effect of Size and Shape of RNA Nanoparticles on Biodistribution.RNA versatility, flexibility, and thermostability for practice in RNA nanotechnology and biomedical applications.Selective Permeability of Uranyl Peroxide Nanocages to Different Alkali Ions: Influences from Surface Pores and Hydration Shells.De novo design of an RNA tile that self-assembles into a homo-octameric nanoprism.Nanotechnology based approaches for detection and delivery of microRNA in healthcare and crop protection.Methods for construction and characterization of simple or special multifunctional RNA nanoparticles based on the 3WJ of phi29 DNA packaging motor.
P2860
Q27679196-CC9D3BC0-830D-485D-B87D-CFB2582AA521Q27690717-F26BEC12-48C9-4C60-9049-B8D2CE8696C6Q28817578-C5853126-665E-4317-8010-095644F97AB0Q33736472-1C3956B5-B0CD-447E-AE57-301BBB8B71DAQ33842009-875F3B12-25BC-427C-8A47-590A21FD1600Q34115320-0390DC16-2560-4BDE-B8CA-1629AD93035FQ35813076-0896B824-B6C8-4B56-A4BD-F239D81B6360Q35865494-3F528BB3-13D3-43DE-B5B6-B3BD52BB6A0FQ36020835-109782A5-60CD-4FB1-9604-051153BD51DCQ36081720-D0858A26-25B0-4743-85FE-8B12262F6824Q36185327-BABD5017-8607-4379-BE6A-AF7EE2704091Q36273286-93495F66-D51A-4A26-AB27-70DEDFEC4B15Q36288499-AC74544E-E695-4FAD-A484-9E2D3A273710Q36338490-4C8C9606-EE70-49F6-AC01-AB936065EA1AQ36449335-48A20132-C8A0-4A39-AAB4-9D4148A34C91Q36522581-72F58073-0564-4906-8E70-DED68CB3F2C6Q37518561-BB6FBD2C-C0DB-4438-BE21-3A24B7F7FBD9Q37530236-6FF4CA4E-2D3C-4C03-999D-BC1CDEF2533EQ37640468-980F19D8-71E8-4051-B4C8-9F4909F4AB07Q38573837-CEEA68D1-B51E-41DF-AE8B-2E0DBD6F63BBQ38812570-71EA4575-1D12-41FF-8821-8AACBDC73DD4Q39065708-E6A12C8F-AA76-4BC3-AACB-A0C4E9C979CEQ40797637-ACA9D74E-BDD0-47C4-A8D9-43CA4DE35928Q41432210-29AABF69-DC60-4FC5-A186-3C6BA3584C63Q41600364-F2AE0F4C-060C-4560-86D3-8C7576D0492AQ41885592-FB6CA401-D21E-45C0-8790-D868CC299D60Q42218319-18AE7360-3F9B-4D3B-B6C9-3A308063D9ADQ45863841-46D05EE9-CAE8-483E-9BFA-BD69D8F233DCQ47097375-9AB11E3E-DEC4-4FEC-8CD1-5338B6686F2BQ47117123-01485ADF-8628-4C2D-9AEF-06DB8187D03FQ47199019-643D40E8-F131-4367-A143-A5F9B41DB801Q48156973-362F3144-6C7D-4665-837A-A490B932F958Q49529515-463D3C5B-E566-44C3-9556-0E3157C413C7Q49904261-AE500517-9620-4130-BB5E-3674650C33ACQ50061940-B2184B48-6F75-4D5F-898E-B0505EC636E7Q50144632-4FB737F6-9CAA-4D07-8223-0AE32429D709Q51645209-BECAB69C-6C33-4B7E-8155-46B7616B9FCDQ51663021-DA176256-F17C-4829-8A45-363BB285AC75Q52589516-71CAE488-80B9-4F78-AAE7-5A0F8E3DB399Q52659947-93400E40-3F60-440B-A8D0-2E602F5ED192
P2860
Fabrication of pRNA nanoparticles to deliver therapeutic RNAs and bioactive compounds into tumor cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fabrication of pRNA nanopartic ...... ve compounds into tumor cells.
@en
Fabrication of pRNA nanopartic ...... ve compounds into tumor cells.
@nl
type
label
Fabrication of pRNA nanopartic ...... ve compounds into tumor cells.
@en
Fabrication of pRNA nanopartic ...... ve compounds into tumor cells.
@nl
prefLabel
Fabrication of pRNA nanopartic ...... ve compounds into tumor cells.
@en
Fabrication of pRNA nanopartic ...... ve compounds into tumor cells.
@nl
P2093
P2860
P356
P1433
P1476
Fabrication of pRNA nanopartic ...... ve compounds into tumor cells.
@en
P2093
P2860
P2888
P304
P356
10.1038/NPROT.2013.097
P577
2013-08-01T00:00:00Z
P6179
1050853322